94 results
S-3
PASG
Passage Bio Inc
4 Mar 24
Shelf registration
4:09pm
to the brain and spinal cord, and an improved safety profile compared with systemic administration due to the lower doses required.
We are currently … administration, which provides the potential for enhanced benefits due to widespread vector delivery to the brain and spinal cord, and an improved safety
8-K
EX-99.2
PASG
Passage Bio Inc
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
of our drug candidates; the occurrence of adverse safety events; the risk that positive results in a preclinical study or clinical trial may … to 15 patients across 3 cohorts Duration 2 years; with additional 3 years of follow-up for safety and durability of effect Primary Endpoints Safety
8-K
EX-99.1
PASG
Passage Bio Inc
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
for Cohort 1 patients in the first half of this year and share 6-month additional safety and biomarker data from Cohort 1 in the second half of 2024 … patients and report 6-month safety and biomarker data in the second half of 2024. Following the positive data, multiple GRN+ patients have been
8-K
EX-99.1
ru181226a37a9l2kt5
5 Jan 24
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
rnkel
20 Dec 23
Passage Bio Announces Promising Initial Data from Phase 1/2 Clinical Trial of PBFT02 In FTD-GRN and Updated Strategic Priorities
7:05am
8-K
uqcbw5 it28zg
20 Dec 23
Passage Bio Announces Promising Initial Data from Phase 1/2 Clinical Trial of PBFT02 In FTD-GRN and Updated Strategic Priorities
7:05am
8-K
EX-99.1
257sbv
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.2
s8ze8pjf452b mnq0uhd
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.3
y0vnpuse
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.2
8a1u6 zu682zt6nrq
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.1
1z3e hcfays6gxw
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.1
8ex57bvdjnchz
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
8-K
EX-99.2
vvk ghs02
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am